PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
743.76 - 757.57
479.80 - 796.25
8.25M / 11.73M (Avg.)
27.40 | 27.58
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.59%
Revenue growth under 50% of BIDU's 14.56%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
15.06%
Gross profit growth similar to BIDU's 15.35%. Walter Schloss would assume both firms track common industry trends.
150.74%
EBIT growth above 1.5x BIDU's 17.12%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
150.74%
Operating income growth above 1.5x BIDU's 17.12%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
62.42%
Net income growth above 1.5x BIDU's 8.59%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
70.81%
EPS growth above 1.5x BIDU's 10.20%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
70.81%
Diluted EPS growth above 1.5x BIDU's 9.18%. David Dodd would see if there's a robust moat protecting these shareholder gains.
28.79%
Share count expansion well above BIDU's 0.04%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
28.79%
Slight or no buyback while BIDU is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
3.31%
OCF growth of 3.31% while BIDU is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
146.20%
FCF growth of 146.20% while BIDU is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
34.25%
10Y revenue/share CAGR under 50% of BIDU's 19930.02%. Michael Burry would suspect a lasting competitive disadvantage.
34.25%
5Y revenue/share CAGR under 50% of BIDU's 1126.06%. Michael Burry would suspect a significant competitive gap or product weakness.
34.25%
3Y revenue/share CAGR under 50% of BIDU's 384.54%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-55.09%
Negative 10Y OCF/share CAGR while BIDU stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-55.09%
Negative 5Y OCF/share CAGR while BIDU is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-55.09%
Negative 3Y OCF/share CAGR while BIDU stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-126.38%
Negative 10Y net income/share CAGR while BIDU is at 44154.19%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-126.38%
Negative 5Y net income/share CAGR while BIDU is 1511.92%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-126.38%
Negative 3Y CAGR while BIDU is 504.89%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.98%
Our AR growth while BIDU is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
7.44%
Asset growth at 50-75% of BIDU's 14.50%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
-17.31%
We have a declining book value while BIDU shows 15.09%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
27.76%
Debt growth far above BIDU's 0.38%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-65.39%
Our R&D shrinks while BIDU invests at 12.65%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-62.69%
We cut SG&A while BIDU invests at 9.39%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.